AU2021338376A1 - Methods and compositions for predicting and/or monitoring diabetes and treatments therefor - Google Patents

Methods and compositions for predicting and/or monitoring diabetes and treatments therefor Download PDF

Info

Publication number
AU2021338376A1
AU2021338376A1 AU2021338376A AU2021338376A AU2021338376A1 AU 2021338376 A1 AU2021338376 A1 AU 2021338376A1 AU 2021338376 A AU2021338376 A AU 2021338376A AU 2021338376 A AU2021338376 A AU 2021338376A AU 2021338376 A1 AU2021338376 A1 AU 2021338376A1
Authority
AU
Australia
Prior art keywords
nucleic acid
snp
cpg
appendix
methylation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021338376A
Other languages
English (en)
Inventor
Meeshanthini V. DOGAN
Timur K. DOGAN
Robert Philibert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Iowa Research Foundation UIRF
Cardio Diagnostics Inc
Original Assignee
University of Iowa Research Foundation UIRF
Cardio Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Iowa Research Foundation UIRF, Cardio Diagnostics Inc filed Critical University of Iowa Research Foundation UIRF
Publication of AU2021338376A1 publication Critical patent/AU2021338376A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Evolutionary Computation (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AU2021338376A 2020-09-04 2021-09-03 Methods and compositions for predicting and/or monitoring diabetes and treatments therefor Pending AU2021338376A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063074836P 2020-09-04 2020-09-04
US63/074,836 2020-09-04
PCT/US2021/049078 WO2022051630A1 (en) 2020-09-04 2021-09-03 Methods and compositions for predicting and/or monitoring diabetes and treatments therefor

Publications (1)

Publication Number Publication Date
AU2021338376A1 true AU2021338376A1 (en) 2023-04-13

Family

ID=80491519

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021338376A Pending AU2021338376A1 (en) 2020-09-04 2021-09-03 Methods and compositions for predicting and/or monitoring diabetes and treatments therefor

Country Status (7)

Country Link
US (1) US20230313302A1 (https=)
EP (1) EP4208571A4 (https=)
JP (1) JP2023541828A (https=)
CN (1) CN116490622A (https=)
AU (1) AU2021338376A1 (https=)
CA (1) CA3194027A1 (https=)
WO (1) WO2022051630A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250130967A1 (en) * 2023-10-20 2025-04-24 Stratus Technologies Ireland Ltd. Systems and methods to preconfigure a hardware module

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9805918D0 (en) * 1998-03-19 1998-05-13 Nycomed Amersham Plc Sequencing by hybridisation
EP1268856A2 (de) * 2000-04-07 2003-01-02 Epigenomics AG Detektion von snp's und cytosin-methylierungen
CN109906275B (zh) * 2016-06-08 2023-05-12 爱荷华大学研究基金会 检测心血管疾病易感性的组合物和方法

Also Published As

Publication number Publication date
CA3194027A1 (en) 2022-03-10
JP2023541828A (ja) 2023-10-04
EP4208571A4 (en) 2024-10-23
US20230313302A1 (en) 2023-10-05
EP4208571A1 (en) 2023-07-12
WO2022051630A1 (en) 2022-03-10
CN116490622A (zh) 2023-07-25

Similar Documents

Publication Publication Date Title
US12043869B2 (en) Compositions and methods for detecting predisposition to cardiovascular disease
US20260035749A1 (en) Methods and compositions for predicting and/or monitoring cardiovascular disease and treatments therefor
Dash et al. Mutational screening of VSX1 in keratoconus patients from the European population
AU2021338376A1 (en) Methods and compositions for predicting and/or monitoring diabetes and treatments therefor
Boonen et al. Two maternal duplications involving the CDKN1C gene are associated with contrasting growth phenotypes
US7807465B2 (en) Methods for identifying an individual at increased risk of developing coronary artery disease
WO2024206958A2 (en) Methods and compositions for predicting and/or monitoring cardiovascular disease and interventions therefor
WO2014067005A1 (en) Novel marker for mental disorders
EP2195448B1 (en) Method to predict iris color
US20100003691A1 (en) Genetic Markers Associated with Degenerative Disc Disease and Uses Thereof
WO2014121180A1 (en) Genetic variants in interstitial lung disease subjects
EP3959333A1 (en) Use of biomarkers for degenerative disc disease
CN105765077B (zh) 测定抗甲状腺药物诱导的粒细胞缺乏症风险的检测方法以及测定用试剂盒
HK40061532A (en) Compositions for detecting predisposition to cardiovascular disease
HK40000428B (en) Compositions for detecting predisposition to cardiovascular disease